Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Izalontamab |
| Trade Name | |
| Synonyms | SI-B001|SI B001|SIB001 |
| Drug Descriptions |
Izalontamab (SI-B001) is a bispecific antibody targeting EGFR and ERBB3 (HER3), which potentially inhibits tumor growth (PMID: 32565357). |
| DrugClasses | EGFR Antibody 73 HER3 (ERBB3) Antibody 28 |
| CAS Registry Number | 2559704-24-2 |
| NCIT ID | C178396 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Carboplatin + Izalontamab + Pemetrexed Disodium | Carboplatin Izalontamab Pemetrexed Disodium | 0 | 0 |
| Docetaxel + Izalontamab | Docetaxel Izalontamab | 0 | 0 |
| Izalontamab | Izalontamab | 0 | 0 |
| Izalontamab + Paclitaxel | Izalontamab Paclitaxel | 0 | 0 |